These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 792850)

  • 41. Experience with 130 consecutive renal transplants in the Middle East with special reference to histocompatibility matching, antirejection therapy with antilymphocyte globulin (ALG), and prolonged preservation of imported cadaveric grafts.
    Abouna GM; Kumar MS; White AG; Daddah S; John P; Samhan M; Omar OF; Kusma G
    Transplant Proc; 1984 Aug; 16(4):1114-7. PubMed ID: 6380057
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.
    Toledo-Pereya LH; Whitten J; Baskin S; McNichol L; Thavarajah K; Lin W
    Bol Asoc Med P R; 1984 Jul; 76(7):293-6. PubMed ID: 6383417
    [No Abstract]   [Full Text] [Related]  

  • 43. Trial of rabbit antihuman ALG in cadaver kidney transplantation.
    Davis RC; Glasgow AH; Williams LF; Nabseth DC; Olsson CA; Schmitt GW; Idelson BA; Cooperband SR; Harrington JT; Mannick JA
    Transplant Proc; 1971 Mar; 3(1):766-8. PubMed ID: 4937970
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract]   [Full Text] [Related]  

  • 45. Controlled clinical trial of antilymphocyte globulin in human renal allografts.
    Birtch AG; Carpenter CB; Tilney NL; Hampers CL; Hager FB; Levine L; Wilson RE; Murray JE
    Transplant Proc; 1971 Mar; 3(1):762-5. PubMed ID: 4937969
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of antilymphocyte globulin in cadaver renal transplantation.
    Novick AC
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of Minnesota antilymphocyte globulin and OKT3 for induction of immunosuppression in renal transplant patients.
    Light JA; Khawand N; Ali A; Brems W; Aquino A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1738-40. PubMed ID: 2652569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract]   [Full Text] [Related]  

  • 49. Low-dose cyclosporine, ALG, and steroids in first cadaveric renal transplants.
    Griño JM; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1987 Oct; 19(5):3674-6. PubMed ID: 3313887
    [No Abstract]   [Full Text] [Related]  

  • 50. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
    Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use and limits of preventive antilymphocyte globulin therapy following kidney transplantation. A prospective randomized study].
    Grundmann R; Wienand P; Meider G; Vlaho V; Pichlmaier H
    Klin Wochenschr; 1984 Oct; 62(20):979-85. PubMed ID: 6389973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A controlled trial antilymphocyte globulin therapy (ALG) in man.
    Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG
    Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965
    [No Abstract]   [Full Text] [Related]  

  • 53. Improved cadaveric kidney graft survival with initiation of antilymphocyte globulin pretransplant in patients with a positive flow cytometry crossmatch.
    Hong JH; Sadeghian M; Sumrani N; Cacciarelli TV; Distant DA; Sommer BG; Norin AJ
    Transplant Proc; 1996 Jun; 28(3):1340-1. PubMed ID: 8658685
    [No Abstract]   [Full Text] [Related]  

  • 54. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation.
    Novick AC; Braun WE; Steinmuller D; Buszta C; Greenstreet R; Kiser W
    Transplantation; 1983 Feb; 35(2):175-9. PubMed ID: 6338636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis.
    Ring J; Seifert J; Anstwurm H; Frick E; Mertin J; Brass B; Backmund H; Lob G
    Postgrad Med J; 1976; 52(5 Suppl):123-30. PubMed ID: 792844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antilymphocyte globulin: a clinical transplantation research opportunity.
    Monaco AP
    Am J Kidney Dis; 1982 Jul; 2(1):67-78. PubMed ID: 7048904
    [No Abstract]   [Full Text] [Related]  

  • 58. Tissue typing, antilymphocyte globulin, and prophylactic graft irradiation in cadaver kidney transplantation.
    Myburgh JA; Goldberg B; Meyers AM; van Blerk PJ; Gecelter L; Mieny CJ; Browde S; Shapiro M; Zoutendyk A; Anderson CG
    Br Med J; 1970 Sep; 3(5724):670-2. PubMed ID: 4919023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged survival time of canine xenografts using a new schedule of horse--anti-dog lymphocytic globulin (ALG) therapy.
    Brendel W; Duswald KH; von Scheel J; Chaussy C; Sollinger HW; Hammer C
    Transplant Proc; 1977 Mar; 9(1):379-81. PubMed ID: 325782
    [No Abstract]   [Full Text] [Related]  

  • 60. Prospective randomized clinical trial in patients with cadaver-kidney transplants.
    Launois B; Campion JP; Fauchet R; Kerbaol M; Cartier F
    Transplant Proc; 1977 Mar; 9(1):1027-30. PubMed ID: 325729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.